Seviterra Tablet 5/40 mg

Adult dose

This medication is administered once daily, 1 tablet, with or without food, preferably at the same time each day (e.g., morning). The maximum dose is 10/40 mg. The recommended doses are as follows: - 5/20 mg: Administered to patients whose blood pressure is not adequately controlled by monotherapy with either amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established.

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, and should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any components of this medication, those who are pregnant or breastfeeding, patients with severely impaired liver or kidney function, specific heart valve diseases, those undergoing biliary obstruction or dialysis, patients in shock, diabetic patients taking certain medications, or those with severely decreased kidney function should not use this medication. Patients with hypotension due to deficiency of fluid or salt should be closely monitored when starting this medication, as their blood pressure may fall sharply; appropriate measures should be taken if hypotension occurs. Patients with severe aortic stenosis should be particularly cautious when taking this medication, as it can cause sudden vasodilation leading to hypotension. In patients with severe coronary artery disease, there is an increased risk of angina or myocardial infarction when taking this medication, and caution is advised. Patients with heart failure should be closely monitored for worsening cardiac function when using this medication. This medication may worsen kidney function in patients with reduced kidney function, and should be used with caution. In patients with impaired liver function, the metabolism of this medication may be slowed, necessitating caution. While taking this medication, side effects such as dizziness, headache, hypotension, gastrointestinal disorders, skin rashes, etc. may occur; if any unusual symptoms arise, immediate consultation with a healthcare professional is advised. During pregnancy, this medication may pose risks to the fetus; therefore, patients who plan to become pregnant or are pregnant should switch to safer alternatives. In breastfeeding patients, this medication may be transferred to breast milk and affect the baby, so it is advisable to stop breastfeeding or discontinue the medication. The safety and efficacy of this medication in children under 18 have not been established, and it is not recommended for use in this population. Elderly patients may experience reduced kidney and liver function, so starting at a low dose and close observation is advisable. In case of overdose, severe hypotension and vascular dilation may lead to heart function issues; immediate emergency treatment is required if symptoms occur. This medication should be stored in a tightly closed container, away from direct sunlight and moisture, out of reach of children. When taking this medication with other drugs, potential interactions may occur, so it is essential to inform healthcare professionals of any current medications.

Serious side effects

Hives, severe swelling (edema), difficulty breathing, respiratory distress, symptoms of shortness of breath, angioedema, liver abnormalities (jaundice) related symptoms, severe skin adverse reactions (severe rash, blisters, skin peeling, mucosal pain in mouth/eyes), severe neurological symptoms (severe headache, seizures, confusion, visual disturbances, paralysis), severe edema or urinary abnormalities (significant reduction in urine output, generalized severe edema, high blood pressure)

Mild side effects

• Dizziness
• headache
• drowsiness
• paresthesia
• reduced sensation
• palpitations
• rapid pulse
• hypotension
• orthostatic hypotension
• cough

This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

Light yellow round film-coated tablets

Package unit

30 tablets/PTP [10 tablets/PTP x3]